Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease
Marc N Potenza*, Valerie Voon and Daniel Weintraub
Correspondence *Yale University School of Medicine, Connecticut Mental Health Center, Room S-104, 34 Park Street, New Haven, CT 06519, USA
Email marc.potenza@yale.edu
A range of impulse control disorders (ICDs), including pathological gambling, compulsive shopping and impulsive aggression, has been recognized in patients with Parkinson's disease (PD). This Review provides the neurologist with an understanding of the clinical and biological features of ICDs and the nature of their relationship with PD. The authors also offer guidance on the management of PD patients with an ICD.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Dopaminergic Modulation of Risk-Based Decision MakingNeuropsychopharmacology Original Article
Response Perseveration and Ventral Prefrontal Sensitivity to Reward and Punishment in Male Problem Gamblers and SmokersNeuropsychopharmacology Original Article
A D2 Antagonist Enhances the Rewarding and Priming Effects of a Gambling Episode in Pathological GamblersNeuropsychopharmacology Original Article
A D2 Antagonist Enhances the Rewarding and Priming Effects of a Gambling Episode in Pathological GamblersNeuropsychopharmacology Original Article
